Related references
Note: Only part of the references are listed.Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma
V. Martini et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2015)
Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation
L. Aresu et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2015)
Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma
K. E. Flood-Knapik et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2013)
Molecular Profiling Reveals Prognostically Significant Subtypes of Canine Lymphoma
A. M. Frantz et al.
VETERINARY PATHOLOGY (2013)
Class II Major Histocompatibility Complex Expression and Cell Size Independently Predict Survival in Canine B-Cell Lymphoma
S. Rao et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2011)
CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma
R. B. Rebhun et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2011)
Classification of Canine Malignant Lymphomas According to the World Health Organization Criteria
V. E. Valli et al.
VETERINARY PATHOLOGY (2011)
Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008)
Lynda M. Beaver et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2010)
Asparaginase and MOPP Treatment of Dogs with Lymphoma
E. M. Brodsky et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
Canine lymphoproliferative disease characterized by lymphocytosis: Immunophenotypic markers of prognosis
M. J. Williams et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry
M. E. Gelain et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2008)
Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed
David M. Lurie et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2008)
Adult T-Cell Leukemia/Lymphoma in Bahia, Brazil
Achilea L. Bittencourt et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy
H. Veelken et al.
ANNALS OF ONCOLOGY (2007)
HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen
Lisa M. Rimsza et al.
LEUKEMIA & LYMPHOMA (2007)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy
F Ponce et al.
VETERINARY JOURNAL (2004)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients
MW Bekkenk et al.
BLOOD (2003)
Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III
TM Holling et al.
JOURNAL OF IMMUNOLOGY (2002)
Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma
K Culmsee et al.
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE (2001)
Share Paper
